Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucoidan for Fatigue and Inflammation in Cancer Survivors
NCT06295588Phase 2Active, not recruiting
- Sponsor
- University of Rochester
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Polysaccharide, Nutraceutical
- Countries
- 1
01
Overview
A Phase 2 trial of fucoidan in fatigue, inflammation, sponsored by University of Rochester. Started Jul 2025; status: active, not recruiting.
02
Drugs
fucoidan
03
Conditions
fatigueinflammation
Beyond the preview
Go deeper on NCT06295588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06295588.